Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

Nottingham-based leading DMPK provider, XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from overseas.Founded in 2011, XenoGesis now has clients across six continents and has experienced consistent growth since day one, with export revenue...

Dr Rachel Hemsley, Global Head of Business Development at Nottingham-based leading DMPK provider XenoGesis, has been appointed to the Advisory Board of BioPartner, the trade organisation for internationalising life sciences companies.BioPartner works closely with UK bioscience sector stakeholders including regional networks, national trade associations, and...

Nottingham, UK – 02 May 2019 BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures.Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...

WASHINGTON—The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has awarded $1,656,206.00 to Halo X-ray Technologies Ltd (HXT) in Nottingham, UK, to develop and implement an automatic threat resolution system for use with X-ray imaging of carry-on and checked baggage.“The potential use of improvised explosive...

BioCity, a pioneering life science incubator and business collective, today announced investment in Deep Branch Biotechnology, a Nottingham-based carbon recycling start-up, developing technology that transforms polluters into producers.Unlike traditional carbon storage technology that simply collects and stores carbon dioxide, Deep Branch’s carbon recycling solution converts...